Digital Health

This study observed a rapid increase in the integration of telehealth- and COVID-19–related apps with electronic health records during the COVID-19 pandemic.

Access to electronic health information can be improved through provider assistance for optimal use of a patient portal.

This new report shows people who used the digital therapeutic saw an improvement of 14% to 15% in their average blood glucose levels regardless of their racial or ethnic category.

Patients are essential stakeholders in designing systems to capture social needs. The authors present key findings from patient interviews regarding social needs screening through technology-based modalities.

Primary care provider burnout was analyzed before and after a national initiative to optimize the electronic health record inbox notification system at the Veterans Health Administration.

Only 18% of US adults with cardiovascular disease (CVD) and 26% of adults at risk for CVD use wearable health devices.

Pear Therapeutics announced positive real-world data for reSET, a prescription digital therapeutic (PDT) for substance use disorder.

A maternal health mobile app helped pregnant women learn more about delivery sanitation, tetanus vaccination, reproductive tract infection symptoms, HIV/AIDS testing, and iron tablet usage.

While 70% of youth engaged with the sickle cell disease (SCD) pain self-management program, only 30% of caregivers engaged with it.

The smartphone app used data from a questionnaire and balance tests to give users an intuitive fall risk score ranging between 0 and 100, indicating low, medium, or high fall risk.

A mobile app providing self-management action advice to patients with inflammatory arthritis (IA) was linked to significant improvements in health-related quality of life (QOL) and disease activity.

As health care shifts reimbursement models from fee-for-service to value-based care, new terms and phrases have been surfacing across the industry. Two of the terms emerging with increased usage are “patient engagement” and an “active patient.” But what do they mean? And why are they important?

The proposed multitask learning (MTL) model was developed using data from wearable devices worn by individuals in a randomized controlled trial (RCT) to predict outcomes of a depression treatment.

Patients with tuberculosis who used a digital medication reminder monitor had better health-related quality of life (HRQOL) and lower catastrophic costs compared with patients who used a standard therapy.

As a result of the potential of digital therapeutics to increase access to personalized care, many choose less stringent minimal control than typically seen in randomized controlled trials (RCTs).

Findings in a small sample of patient-caregiver dyads demonstrated high potential for a music intervention’s use in dementia care.

A digital pet app used as a prescription digital therapeutic (PDT) to encourage children to complete prescribed therapies received high engagement and function scores from children living with neurodevelopmental disabilities.

New studies have linked a diet of ultra-processed food to a higher risk of colorectal cancer and to an overall risk of mortality; the CDC endorsed the updated booster shots from Moderna and Pfizer-BioNTech for use against the omicron variant; South Carolina Department of Corrections and Pear Therapeutics are teaming up to support inmates recovering from substance use disorders.

Wearing a physical activity tracker and receiving personalized exercise feedback was linked to better results in exercise performance, weight loss, and other health outcomes among individuals with obesity.

Use of prototype app UpSilent resulted in clinically meaningful changes in tinnitus and superior outcomes across most measures after 12 weeks compared with popular app White Noise.

Children whose parents were more engaged with an intervention focused on obesity saw greater results compared with children whose parents were less engaged.

Researchers found automated foot strike detection is viable for smartphone-based fall risk classification in patients with lower limb amputations.

After 2 years of follow-up, more than a quarter of patients who used a digital therapeutic delivering cognitive behavioral therapy for insomnia achieved insomnia remission.

Researchers developed a framework to pull high-resolution digital phenotypes from wearable devices and use them to predict the risk of cardiometabolic disease.

The mobile intervention, based on the Integrated Theory of Health Behavior Change, significantly improved self-management behaviors among patients with tuberculosis (TB).

Participants in a digital acute musculoskeletal program experienced better pain and function outcomes compared with nonparticipants, demonstrating benefits for acute and subacute musculoskeletal conditions.

To reduce bias based on the user’s current health status, a mobile health intervention used a future-self avatar to help individuals understand long-term effects of physical activity and nutrition on their body.

Two medical experts relay their ideas on how to better improve the payer-provider relationship surrounding PDT use.

Panelists at the National Alliance of Healthcare Purchaser Coalitions 2022 Leadership Summit discussed the latest innovations in digital therapeutics and how they benefit patients on an individual and broad scale.

Digital health care has been a key initiative at Texas Oncology, because it ensure patients can receive better care at their home, explained Debra Patt, MD, PhD, MBA, executive vice president of Texas Oncology.